Exact Mass: 592.418626
Exact Mass Matches: 592.418626
Found 427 metabolites which its exact mass value is equals to given mass value 592.418626,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Feruloyldihydro-beta-sitosterol
Feruloyldihydro-beta-sitosterol is found in cereals and cereal products. Feruloyldihydro-beta-sitosterol is isolated from maize bran oil. Isolated from maize bran oil. Feruloyldihydro-beta-sitosterol is found in cereals and cereal products and corn.
Tuberoside
Tuberoside is found in mushrooms. Tuberoside is a constituent of Chinese truffles (Tuber indicum). Constituent of Chinese truffles (Tuber indicum). Tuberoside is found in mushrooms.
Avenestergenin B2
Avenestergenin B2 is found in cereals and cereal products. Aglycone from oat root. Aglycone from oat root. Avenestergenin B2 is found in cereals and cereal products.
Ubiquinol-6
UbUbiquinone(Q) is an essential, lipid soluble, redox component of the mitochondrial respiratory chain. Much evidence suggests that ubiquinol (QH2) functions as an effective antioxidant in a number of membrane and biological systems by preventing peroxidative damage to lipids. It has been proposed that superoxide dismutase (SOD) may protect QH2 from autoxidation by acting either directly as a superoxide−semiquinone oxidoreductase or indirectly by scavenging superoxide. (Biochemistry, 1996, 35 (21), pp 6595 - 6603) [HMDB] UbUbiquinone(Q) is an essential, lipid soluble, redox component of the mitochondrial respiratory chain. Much evidence suggests that ubiquinol (QH2) functions as an effective antioxidant in a number of membrane and biological systems by preventing peroxidative damage to lipids. It has been proposed that superoxide dismutase (SOD) may protect QH2 from autoxidation by acting either directly as a superoxide−semiquinone oxidoreductase or indirectly by scavenging superoxide. (Biochemistry, 1996, 35 (21), pp 6595 - 6603).
iso-A2E(11-cis)
This compound belongs to the family of Sesquiterpenes. These are terpenes with three consecutive isoprene units.
iso-A2E(13-cis)
This compound belongs to the family of Sesquiterpenes. These are terpenes with three consecutive isoprene units.
iso-A2E(9-cis)
This compound belongs to the family of Sesquiterpenes. These are terpenes with three consecutive isoprene units.
iso-A2E(9,13-di-cis)
This compound belongs to the family of Sesquiterpenes. These are terpenes with three consecutive isoprene units.
N-Retinylidene-N-retinylethanolamine
This compound belongs to the family of Sesquiterpenes. These are terpenes with three consecutive isoprene units. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
PA(20:0/8:0)
PA(20:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/8:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/20:0)
PA(8:0/20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/20:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(10:0/i-18:0)
PA(10:0/i-18:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-18:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isooctadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/i-20:0)
PA(8:0/i-20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-20:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isoeicosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(a-13:0/a-15:0)
PA(a-13:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/a-15:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(a-13:0/i-15:0)
PA(a-13:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-15:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-12:0/i-16:0)
PA(i-12:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-16:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-13:0/a-15:0)
PA(i-13:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/a-15:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-13:0/i-15:0)
PA(i-13:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-15:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-14:0/i-14:0)
PA(i-14:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-14:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-20:0/8:0)
PA(i-20:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-20:0/8:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
Di-8-ANEPPS
DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)
DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))
DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)
DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))
DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)
DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))
DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)
DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))
DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)
DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))
DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)
DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Ikshusterol 3-O-glucoside
3-(4-Hydroxybenzoyl)-1,3-Dihydroxy-14-taraxeren-28-oic acid
3-(3,4-dihydroxyphenyl)-acrylic acid-21-(2,3-dihydroxypropoxycarbonyl)-heneicosyl ester
3-O-alpha-L-Fucopyranoside-Ergosta-5,24(28)-diene-3,9,11,16-tetrol
(24R)-24-ethyl-6beta-[(beta-D-glucopyranosyl)oxy]-5beta-cholest-9-ene-12alpha-ol|opuntisteroside
(4E)-1-(2,4-dihydroxyphenyl)-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-8-hydrox-5,9,13-trimethyl-6,9-oxo-tetradeca-4,12-diene-1-one|ferulaeone H
25-O-acetyl-3-O-[beta-L-arabinopyranosyl]cholest-5-ene-3beta,19,25-triol|junceelloside C
15alpha-benzoyloxy-3beta,11alpha,12-trihydroxyurs-12-en-24-al
3beta-acetoxy-27-(p-hydroxyl)benzoyloxylup-20(29)-en-28-oic acid
(24S)-ergostane-1beta,3beta,5alpha,6beta-tetraol 1,3,6-triacetate
5alpha,8alpha-epidioxy-24(R)-methylcholesta-6,22-dien-3beta-D-glucopyranoside
4-O-acetyl-3-O-[beta-D-arabinopyranosyl-oxy]-cholest-5-ene-3beta,19,25-triol|junceelloside A
3-O-acetyl-3-O-[beta-D-arabinopyranosyl-oxy]-cholest-5-ene-3beta,19,25-triol|junceelloside B
Gallinamide A
D000890 - Anti-Infective Agents > D023181 - Antimicrobial Cationic Peptides
Dimyristoyl phosphatidic acid
A phosphatidic acid in which the phosphatidyl acyl groups are both myristoyl.
Dimyristoyl-sn-glycerol 3-phosphate
Dimyristoyl-sn-glycerol 3-phosphate (DMPG) is a type of phospholipid that plays a crucial role in biological systems, particularly in the structure and function of cell membranes. Here's a detailed description of its biological functions: 1. **Cell Membrane Formation**: DMPG, like other phospholipids, is a key component of cell membranes. It has a hydrophilic (water-attracting) head composed of a glycerol molecule linked to a phosphate group and two hydrophobic (water-repelling) tails made up of myristic acid chains. This amphipathic nature allows DMPG to form lipid bilayers in aqueous environments, which is the basic structure of cell membranes. 2. **Membrane Fluidity**: The presence of myristic acid chains in DMPG contributes to the fluidity of cell membranes. The length and saturation of the fatty acid tails influence how tightly packed the phospholipids are in the membrane. Myristic acid, being a saturated fatty acid, tends to pack more closely, which can decrease membrane fluidity. This is important for maintaining the integrity and functionality of the membrane. 3. **Signal Transduction**: Phospholipids, including DMPG, are involved in signal transduction pathways within cells. Changes in the concentration or distribution of phospholipids can affect the activity of membrane-bound proteins, such as enzymes and receptors, which are critical for cellular signaling. 4. **Biosynthesis of Other Lipids**: DMPG serves as a precursor for the synthesis of other important lipids in the cell. For example, it can be converted into other types of phospholipids or used in the synthesis of complex lipids like sphingolipids. 5. **Role in Vesicular Transport**: In cells, DMPG is involved in the formation of transport vesicles that carry molecules within the cell and to the cell membrane. This process is essential for intracellular trafficking and secretion. 6. **Potential Involvement in Disease**: Altered levels or metabolism of phospholipids, including DMPG, have been associated with various diseases, including cardiovascular diseases and cancer. Understanding the role of DMPG in these conditions can provide insights into disease mechanisms and potential therapeutic targets.
Avenestergenin B2
Tuberoside
Sitostanyl ferulate
N-behenoyl-O-phosphocholineserine
C30H61N2O7P (592.4216165999999)
A2-E
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
Di-8-ANEPPS
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
1-Hydroxy-3-((4-hydroxybenzoyl)oxy)-D-friedoolean-14-en-28-oic acid (1beta,3beta)-
(1r)-2-(Phosphonooxy)-1-[(Tridecanoyloxy)methyl]ethyl Pentadecanoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] octadecanoate
(2R)-1-(decanoyloxy)-3-(phosphonooxy)propan-2-yl octadecanoate
2-[[(2R)-2-butanoyloxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (13Z,16Z)-tetracosa-13,16-dienoate
(2-Acetamido-3-hydroxytetracosyl) 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexanoylamino)-3-hydroxyicosyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Heptanoylamino)-3-hydroxynonadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Butanoylamino)-3-hydroxydocosyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Heptadecanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(octanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(pentanoylamino)henicosyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[3-Hydroxy-2-(nonanoylamino)heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[3-Hydroxy-2-(propanoylamino)tricosyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[2-(Decanoylamino)-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(tridecanoylamino)tridecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(pentadecanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(tetradecanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(undecanoylamino)pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexadecanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Dodecanoylamino)-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(octadecanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) docosanoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) pentacosanoate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) hexacosanoate
(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate
(1-Octanoyloxy-3-phosphonooxypropan-2-yl) icosanoate
(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate
(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate
(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) pentadecanoate
(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) heptadecanoate
(1-Decanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] heptadecanoate
N-(dodecanoyl)-tetradecasphinganine-1-phosphocholine
[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-dodec-5-enoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-hydroxy-3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium
[3-[2,3-bis[[(6E,9E)-dodeca-6,9-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium
[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-dodec-5-enoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] heptadecanoate
[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate
[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium
2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropoxy]propyl]-trimethylazanium
2-[hydroxy-[2-nonanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-butanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[3-[3-butanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
2-[hydroxy-[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-acetyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[3-hexanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
[3-[3-acetyloxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
2-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-heptanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-heptanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
2-[hydroxy-[3-octoxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-butanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-nonoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-octanoyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(Z)-henicos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-decoxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-decanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(Z)-heptadec-9-enoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
N-Retinylidene-N-retinylethanolamine
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
1beta-hydroxymaprounic acid 3-p-hydroxybenzoate
A pentacyclic triterpenoid that is the benzoate ester obtained by the condensation of the 3-hydroxy group of 1beta-hydroxymaprounic acid with p-hydroxybenzoic acid. Isolated from Maprounea africana, it exhibits inhibitory activity against HIV-1 reverse transcriptase.
1-decanoyl-2-stearoyl-sn-phosphatidic acid
A 1,2-diacyl-sn-glycerol 3-phosphate (sn-phosphatidic acid) in which the acyl groups at positions 1 and 2 are specified as decanoyl and stearoyl respectively.
1,2-ditetradecanoyl-sn-glycerol-3-phosphate
A 1-acyl-2-tetradecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as tetradecanoyl (myristoyl).
SM(26:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LCL521
LCL521 is an acid ceramidase (ACDase) inhibitor. LCL521 also inhibits the lysosomal acid sphingomyelinase (ASMase)[1].
(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5s)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-{[1-(5,6-dimethylhept-3-en-2-yl)-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
6-{2-[7-(acetyloxy)-3-hydroxy-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-2,2,5a,7-tetramethyl-3-oxo-hexahydro-1-benzoxepin-7-yl acetate
(2r,3r,4s,5r)-2-{[(2z,6r)-6-[(1r,3r,5s,5as,7s,9ar,9br,11ar)-3,5,7-trihydroxy-9a,11a-dimethyl-1h,2h,3h,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-3-isopropylhept-2-en-1-yl]oxy}oxane-3,4,5-triol
(5s)-3-{[(2s,6r)-6-[(7s)-7-hydroxy-7-[(2s,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one
(1z,6s,9r)-9-[(1r,3as,3br,9as,9bs,11ar)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-6-isopropyldec-1-en-3-one
(3s,5as,6s,7s,9as)-3-(acetyloxy)-6-{2-[(1s,2r,3r,6s,9r)-9-hydroxy-2,3,8,8-tetramethyl-7,12-dioxatricyclo[7.2.1.0¹,⁶]dodecan-2-yl]ethyl}-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate
(1s,5r,6r,7r,8s,9z,11s,15e,17r)-1,7,11-trihydroxy-5-[(2s,4s,5r,6r)-5-hydroxy-4,6-dimethyl-7-oxononan-2-yl]-6,8,16,18-tetramethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,15,18-trien-3-one
1,7,11-trihydroxy-5-(5-hydroxy-4,6-dimethyl-7-oxononan-2-yl)-6,8,16,18-tetramethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,15,18-trien-3-one
2-{[1-(7-hydroxy-5-isopropylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
4-{[1-hydroxy-3a,6,6,9a,11a-pentamethyl-1-(5,6,7-trihydroxy-6-methylheptan-2-yl)-2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-oxobutanoic acid
2-{[2-(dimethylamino)-3-methylpentanoyl]oxy}-n-(1-{[5-(3-methoxy-2-methyl-5-oxo-2h-pyrrol-1-yl)-5-oxopent-3-en-2-yl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-4-methylpentanimidic acid
(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,4r,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(3s,14s,15s)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-15-(pentadecan-2-yl)-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid
(5r)-3-{[(2s,5s)-5-[(8s)-8-hydroxy-8-[(2s,5s)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxooctyl]oxolan-2-yl]methyl}-5-methyl-5h-furan-2-one
(1r,5as,7s,9as,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl 3-(4-hydroxyphenyl)prop-2-enoate
(5s)-3-{[(2r,6s)-6-[(7r)-7-hydroxy-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one
(1r,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3a-yl 3,4-dimethoxybenzoate
2-{[(1r,3ar,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
6-[9a-(hydroxymethyl)-11a-methyl-7-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylheptan-2-yl acetate
(6r)-6-[(1r,3as,3bs,7s,9as,9bs,11ar)-9a-(hydroxymethyl)-11a-methyl-7-{[(2s,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylheptan-2-yl acetate
(3s,6r)-6-[(1r,3as,3br,9as,9bs,11ar)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-3-isopropylheptyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
5-methoxy-2-[18-(4-methoxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-1,3,3-trimethylcyclohex-1-ene
16-ethyl-9-{16-ethyl-7-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium-6-yl}-8-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium
[C38H48N4O2]2+ (592.3777067999999)
2-{[1-(5-ethyl-6-methylheptan-2-yl)-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-{[5-(5,6-dimethylhept-3-en-2-yl)-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadecan-13-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s)-2-{[(2s)-2-{[(2s,3s)-2-(dimethylamino)-3-methylpentanoyl]oxy}-1-hydroxy-4-methylpentylidene]amino}-n-[(2s,3e)-5-[(2s)-3-methoxy-2-methyl-5-oxo-2h-pyrrol-1-yl]-5-oxopent-3-en-2-yl]-4-methylpentanimidic acid
1-(2,4-diphenyl-3-{3-[(2r)-piperidin-2-yl]-5,6-dihydro-4h-pyridine-1-carbonyl}cyclobutanecarbonyl)-3-[(2r)-piperidin-2-yl]-5,6-dihydro-4h-pyridine
C38H48N4O2 (592.3777067999999)